Depression-, Pain-, and Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus

por Chalhoub, Nathalie E., Luggen, Michael E.
Publicado 2022

Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor in...

por Feist, Eugen, Fatenejad, Saeed, Grishin, Sergey, Korneva, Elena, Luggen, Michael E, Nasonov, Evgeniy, Samsonov, Mikhail, Smolen, Josef S, Fleischmann, Roy M
Publicado 2022

Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study

por Mease, Philip J, Chohan, Saima, Fructuoso, Ferran J Garcia, Luggen, Michael E, Rahman, Proton, Raychaudhuri, Siba P, Chou, Richard C, Mendelsohn, Alan M, Rozzo, Stephen J, Gottlieb, Alice
Publicado 2021